Skip to content
Rheumatology · Southern California

Rheumatology Medical Billing for Southern California Practices

Rheumatology revenue is concentrated in infusion and injectable drugs, where J-code units, buy-and-bill margins, and biologic prior authorizations determine whether the practice is paid or exposed. Quantix Health manages drug and administration coding alongside E/M and injections so high-cost therapies are authorized and reimbursed accurately.

  • Accurate J-code drug and units reporting for infusions and injectables
  • Biologic and infusion prior authorization managed before each administration
  • Correct E/M with same-day joint injection and infusion administration coding
Why rheumatology practices choose us

Specialty expertise, not generic billing

J-code and unit accuracy

We report infusion and injectable drugs with correct HCPCS J-codes, units, and wastage documentation so buy-and-bill claims reflect exactly what was administered.

Biologic prior auth

High-cost biologics and infusions are authorized before each administration, with step-therapy and reauthorization tracked so therapy is never delivered without coverage in place.

Buy-and-bill protection

We reconcile drug acquisition against reimbursement so the practice is not left carrying the cost of denied or underpaid high-dollar therapies.

E/M plus procedures

Same-day evaluation, joint injections, and infusion administration are coded with correct modifiers so all distinct services are captured without bundling denials.

Common billing challenges

Where rheumatology practices lose revenue

These are the specialty-specific leaks we watch for — and fix at the root.

  • Biologic and infusion therapies administered without a valid prior authorization, leaving high-dollar claims denied
  • J-code units or wastage reported incorrectly, causing drug underpayment or overpayment recoupment
  • Step-therapy and reauthorization lapses interrupting ongoing biologic coverage
  • Infusion administration time and hierarchy (initial, sequential, concurrent) coded incorrectly
  • Same-day E/M with joint injection denied for missing modifier 25 or medical-necessity support
  • Buy-and-bill drug acquisition costs exceeding reimbursement when denials or contract underpayments are not caught
FAQ

Common questions

How do you protect our buy-and-bill margin?

We confirm prior authorization before each administration, report J-codes and units precisely with wastage documentation, and reconcile drug acquisition against reimbursement so denials and underpayments are caught and appealed.

Do you manage biologic prior authorizations and reauthorizations?

Yes. We handle initial authorizations, step-therapy requirements, and scheduled reauthorizations across Medicare, managed-care, and commercial plans so ongoing therapy is not interrupted.

How do you code infusion administration and same-day visits?

We apply the correct initial, sequential, and concurrent infusion codes by time and hierarchy, and bill same-day E/M with joint injections using appropriate modifiers when documentation supports separate services.

Related resources

Billing guides for rheumatology practices

Let's strengthen your rheumatology revenue

Book a free, no-obligation consultation. We'll review your billing and show you the opportunity — no pressure.